Serum galactomannan antigen test for the diagnosis of chronic pulmonary aspergillosis

Journal of Infection

Volumn 68, Issue 5, 2014, Pages 494-499

  Shin, Beomsu ^a   Koh, Won Jung ^a   Jeong, Byeong Ho ^a   Yoo, Hongseok ^a   Park, Hye Yun ^a   Suh, Gee Young ^a   Kwon, O Jung ^a   Jeon, Kyeongman ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Diagnosis; Galactomannan; Pulmonary aspergillosis; Serum

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC PULMONARY ASPERGILLOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FUNGAL EXAMINATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HUMAN; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERUM GALACTOMANNAN ANTIGEN TEST; BLOOD; CHEMISTRY; CHRONIC DISEASE; EVALUATION STUDY; PROCEDURES; PULMONARY ASPERGILLOSIS; SEROLOGY; SERUM;

BIOLOGICAL MARKER; FUNGUS ANTIGEN; GALACTOMANNAN; MANNAN;

AGED; ANTIGENS, FUNGAL; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MANNANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY ASPERGILLOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SERUM;

EID: 84897963073     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.01.005     Document Type: Article

References (15)

1. Walsh T.J., Anaissie E.J., Denning D.W., Herbrecht R., Kontoyiannis D.P., Marr K.A., et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46:327-360.
2. Smith N.L., Denning D.W. Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J 2011, 37:865-872.
3. Camuset J., Nunes H., Dombret M.C., Bergeron A., Henno P., Philippe B., et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 2007, 131:1435-1441.
4. Ohba H., Miwa S., Shirai M., Kanai M., Eifuku T., Suda T., et al. Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med 2012, 106:724-729.
5. Cadranel J., Philippe B., Hennequin C., Bergeron A., Bergot E., Bourdin A., et al. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis 2012, 31:3231-3239.
6. Denning D.W., Riniotis K., Dobrashian R., Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003, 37(Suppl. 3):S265-S280.
7. Zmeili O.S., Soubani A.O. Pulmonary aspergillosis: a clinical update. QJM 2007, 100:317-334.
8. Nam H.S., Jeon K., Um S.W., Suh G.Y., Chung M.P., Kim H., et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 2010, 14:e479-e482.
9. Jhun B.W., Jeon K., Eom J.S., Lee J.H., Suh G.Y., Kwon O.J., et al. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. Med Mycol 2013, 51:811-817.
10. Kitasato Y., Tao Y., Hoshino T., Tachibana K., Inoshima N., Yoshida M., et al. Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis. Respirology 2009, 14:701-708.
11. Mennink-Kersten M.A., Donnelly J.P., Verweij P.E. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004, 4:349-357.
12. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
13. Kono Y., Tsushima K., Yamaguchi K., Kurita N., Soeda S., Fujiwara A., et al. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Respir Med 2013, 107:1094-1100.
14. Izumikawa K., Yamamoto Y., Mihara T., Takazono T., Morinaga Y., Kurihara S., et al. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis. Med Mycol 2012, 50:811-817.
15. Park S.Y., Lee S.O., Choi S.H., Jeong J.Y., Sung H., Kim M.N., et al. Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma. Clin Infect Dis 2011, 52:e149-e152.